Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Human Placental-Derived Stem Cell Transplantation

NCT01586455

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
Locations
  • Children's Hospital Colorado Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
  • University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

NCT01380145

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • New York University School of Medicine New York, United States
  • Mount Sinai Hospital New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Treatment for Advanced B-Cell Lymphoma

NCT01859819

Conditions
Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +18 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • New York Medical College Valhalla, New York, United States
  • Levine Children's Hospital Charlotte, North Carolina, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Ublituximab + Ibrutinib in Select B-cell Malignancies

NCT02013128

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Tucson, Arizona, United States
  • TG Therapeutics Investigational Trial Site Santa Barbara, California, United States
  • TG Therapeutics Investigational Trial Site Boulder, Colorado, United States
View all 18 locations
View Trial Details
Completed

Therapy for Pediatric Hodgkin Lymphoma

NCT00145600

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Stanford University Palo Alto, California, United States
  • Maine Children's Cancer Program Portland, Maine, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

NCT02164955

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Cliniques Universitaires Saint Luc Brussels, Avenue Hippocrate 10, Belgium
  • Ziekenhuis Netwerk Antwerpen- Campus Middelheim Antwerp, Lindendreef 1, Belgium
  • Az Nikolaas Sint-Niklaas, Lodewijk de Meesterstraat 5, Belgium
  • Centre Hospitalier Peltzer-La Tourelle Verviers, Rue Du Parc 29, Belgium
View all 122 locations
View Trial Details
Completed

Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation

NCT02535286

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • TG Therapeutics Investigational Trial Site New York, United States
  • TG Therapeutics Investigational Trial Site Durham, North Carolina, United States
  • TG Therapeutics Investigational Trial Site Philadelphia, Pennsylvania, United States
  • TG Therapeutics Investigational Trial Site Seattle, Washington, United States
View Trial Details

Related conditions